Results of immunohistochemistry (IHC; Figure 5A) and expression analysis demonstrated that the expression of SFN in primary tumor tissue from NSCLC patients was significantly higher than that in adjacent non-tumor tissues (p < 0.01; Figure 5B). The gene discussed is SFN; the disease is neoplasm.